Pharmacokinetics properties of surface-modified vesicles

Keitaro Sou*, Beth Coins, William T. Phillips, Shinji Takeoka, Eishun Tsuchida

*この研究の対応する著者

研究成果: Paper査読

抄録

Phospholipid vesicles, also called liposome, are potent carriers of various drugs and offer a drug targeting system into specific organs, tissues, or cells, to minimize the drug administration dose and improve the therapeutic safety. Recently, we have found that phospholipid vesicle containing an anionic amphiphile; 1,5-dihexadecyl-L-glutamate-N-succinic acid (Suc-2C 16) and polyethylene glycol)-lipid (PEG-DSPE) are mainly up taken by rabbit bone marrow at a small injection dose (15 mg/kg b.w.). At 24 h after intravenous injection of 99m-technetimu ( 99mTc)-labeled vesicles in rabbit, biodistribution data clearly indicated that the component of Suc-2C 16 induced the significant affinity to bone marrow in comparison with control vesicles, which do not have Suc-2C 16. Further incorporation of as little as 0.6 mol% of PEG-DSPE passively enhanced the distribution of Suc-Ve into bone marrow inhibiting the liver uptake, and this formulation was distributed in the bone marrow over the whole body, reaching to 70% of the injected dose by 6 h after injection.

本文言語English
ページ3046-3047
ページ数2
出版ステータスPublished - 2005 12月 1
イベント54th SPSJ Symposium on Macromolecules - Yamagata, Japan
継続期間: 2005 9月 202005 9月 22

Other

Other54th SPSJ Symposium on Macromolecules
国/地域Japan
CityYamagata
Period05/9/2005/9/22

ASJC Scopus subject areas

  • 工学一般

フィンガープリント

「Pharmacokinetics properties of surface-modified vesicles」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル